MolGraph
CompoundsDocumentationComplianceAbout
MolGraph

Research chemical sourcing and molecular building block RFQ workflows.

MolGraph is operated by Tessorix Inc.

support@molgraph.com

Products are intended for laboratory research use only and are not for human or veterinary use.

Compounds

  • Compound catalog
  • CAS Search

Company

  • About
  • Contact

Documentation

  • Quality Documentation
  • SDS Disclaimer

Compliance

  • Compliance

Legal

  • Terms
  • Privacy

Copyright © 2026 MolGraph. All Rights Reserved.

Home/Compounds/CAS 259793-96-9
Formula C5H4FN3O2MW 157.1Research-use catalog entryCOA/SDS by request

Favipiravir

CAS Number: 259793-96-9

Sourcing & RFQ

Submit an RFQ to review pricing, availability, lead time, pack size, purity, COA, and supplier SDS for this catalog entry.

Available options

Available Options

Package
1 g
Purity
99%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
100 g
Purity
99%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
100 mg
Purity
99%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
25 g
Purity
99%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
250 mg
Purity
99%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
5 g
Purity
99%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required

Shipping review is required before pricing or stock can be confirmed publicly. Shipping, duties, and documentation fees are confirmed before order acceptance.

Loading RDKit molecule structure...
InChIKey: ZCGNOVWYSGBHAU-UHFFFAOYSA-NC5H4FN3O2 | MW 157.1

Chemical Absolute Identifiers

CAS Number

259793-96-9

PubChem CID

492405

Molecular Formula

C5H4FN3O2

Molecular Weight

157.1 g/mol

Exact Mass

157.028755

InChIKey

ZCGNOVWYSGBHAU-UHFFFAOYSA-N

IUPAC Name

5-fluoro-2-oxo-1H-pyrazine-3-carboxamide

SMILES String

C1=C(N=C(C(=O)N1)C(=O)N)F

Physical Properties

pKa

5.1

Properties are provided as catalog reference data and may be confirmed through supplier documentation when required.

Catalog Facts

Structural features

Favipiravir (CAS 259793-96-9) is listed in the Pharmaceutical Intermediates portfolio, with molecular formula C5H4FN3O2 and molecular weight 157. 10 g/mol.

Sourcing context

Catalog reference for RFQ preparation, supplier confirmation, and research chemical sourcing review.

Research use context

Intended for research-stage medicinal chemistry and intermediate synthesis workflows; structure-derived tags include nitrogen-containing heterocycle.

Documentation needs

COA/SDS status, availability, lead time, pack size, and shipment documentation can be confirmed during quotation.

Applications & Classification

Pharmaceutical Intermediate ResearchResearch intermediateCustom synthesis building blockPharmaceutical intermediate researchResearch chemical sourcingCustom synthesis and catalog availability reviewCOA, SDS, pricing, and fulfillment workflow
Biological target reference

ChEMBL reports experimental activity evidence for: Alpha-1A adrenergic receptor (Homo sapiens) — 2 assays; Muscarinic acetylcholine receptor M1 (Homo sapiens) — 2 assays; Prostaglandin G/H synthase 1 (Homo sapiens) — 2 assays; Protein deacetylase HDAC6 (Homo sapiens) — 2 assays; Thromboxane A2 receptor (Homo sapiens) — 2 assays. These records describe research assays and do not establish therapeutic efficacy or clinical use.

Alpha-1A adrenergic receptor

Homo sapiens · SINGLE PROTEIN · 2 qualifying assays · 1 documents

Experimental evidence source: ChEMBL

Muscarinic acetylcholine receptor M1

Homo sapiens · SINGLE PROTEIN · 2 qualifying assays · 1 documents

Experimental evidence source: ChEMBL

Prostaglandin G/H synthase 1

Homo sapiens · SINGLE PROTEIN · 2 qualifying assays · 1 documents

Experimental evidence source: ChEMBL

Protein deacetylase HDAC6

Homo sapiens · SINGLE PROTEIN · 2 qualifying assays · 1 documents

Experimental evidence source: ChEMBL

Thromboxane A2 receptor

Homo sapiens · SINGLE PROTEIN · 2 qualifying assays · 1 documents

Experimental evidence source: ChEMBL

Safety & Handling

Safety and handling reference content is available through documentation requests.

For supplier-issued SDS, request documentation before handling, storage, shipment, or procurement decisions.

Preliminary Safety Reference

For supplier-issued SDS or COA, submit a documentation request.

Safety Reference / SDS Request

Names & Synonyms / External Identifiers

Chemical Name

Favipiravir

Names & Synonyms

avigan6-FLUORO-3-HYDROXYPYRAZINE-2-CARBOXAMIDET-7056-fluoro-3-hydroxy-2-pyrazinecarboxamideT 705
Show all synonyms
FapilavirFavilavirT-705 cpd2-Pyrazinecarboxamide, 6-fluoro-3-hydroxy-favipiravirumAvipiravir6-fluoro-3-oxo-3,4-dihydropyrazine-2-carboxamideFavipiravir (T-705)2-Pyrazinecarboxamide, 6-fluoro-3,4-dihydro-3-oxo-Pyrazinecarboxamide, 6-fluoro-3,4-dihydro-3-oxo-6-fluoro-3-hydroxy-pyrazine-2-carboxamideFavipiravir [INN]Favipiravir [USAN:INN:JAN]6-fluoro-3,4-dihydro-3-oxo-Pyrazinecarboxamide
External Identifiers
EC NUMBER: 856-840-0DSSTOX SUBSTANCE ID: DTXSID60948878CHEMBL ID: CHEMBL221722CHEBI ID: CHEBI:134722UNII: EW5GL2X7E0DRUGBANK ID: DB12466HMDB ID: HMDB0252176KEGG ID: D09537METABOLOMICS WORKBENCH ID: 144533NCI THESAURUS CODE: C81605PHARMGKB ID: PA166196742WIKIDATA ID: Q16934561
Literature & Patent References
DOI 10.1016/j.bmcl.2025.130110Nucleoside antiviral agents with atypical structures and new targets.DOI 10.1021/acs.jmedchem.5c00615From Diarylsulfides to Diarylamines: New Ebola Virus Entry Inhibitors with Improved Metabolic Stability.DOI 10.1021/acs.jmedchem.5c00626Design and Development of a Novel Oral 4'-Fluorouridine Double Prodrug VV261 against SFTSV.PMID 39864529Nucleoside antiviral agents with atypical structures and new targets.PMID 40294286Design and Development of a Novel Oral 4'-Fluorouridine Double Prodrug VV261 against SFTSV.PMID 40381209From Diarylsulfides to Diarylamines: New Ebola Virus Entry Inhibitors with Improved Metabolic Stability.DOI 10.1016/j.bmc.2023.117552Elongation of N<sup>6</sup>-benzyladenosine scaffold via Pd-catalyzed C-C bond formation leads to derivatives with antiflaviviral activity.DOI 10.1016/j.ejmech.2024.116737Optimization of potent, broad-spectrum, and specific anti-influenza compounds targeting RNA polymerase PA-PB1 heterodimerization.

Documentation & Compliance Facts

Compliance Facts

Shipment review: Required

Documentation available by request

Certificate of Analysis (COA): By request

Supplier Safety Data Sheet (SDS): By request

Purity and pack size confirmation: By request

Availability and lead time review: Confirmed by RFQ

Shipment documentation review: By request

For supplier-issued documentation by request, use the RFQ actions on this page.Review preliminary safety reference

What happens after RFQ

  1. 1We review the CAS identity, quantity, and documentation request.
  2. 2We check sourcing options, supplier availability, COA/SDS, purity, pack size, and lead time.
  3. 3We review destination and shipment documentation needs when applicable.
  4. 4We follow up with a quotation or clarification request.

Text Reference Cues

Show non-linked catalog cues

Non-public related references

5-Fluoro-isoxazolo[4,5-b]pyrazine-3-carboxylic acid methyl esterCAS 1374986-06-7

Non-public references are shown as text only and do not imply equivalence, availability, or shared use.

Catalog navigation

Related Catalog Entries

Other public CAS pages in this catalog. These links support navigation across additional intermediates and do not imply equivalence, availability, or shared use.

CAS 100643-71-8DesloratadineCAS 102767-28-2LevetiracetamCAS 106635-80-7TafenoquineCAS 1002310-00-0Tert-butyl 1-(2-chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethylcarbamateCAS 1005174-17-3(E)-3-(2-Propyl-6-(trifluoromethyl)pyridin-3-yl)acrylic acidCAS 1018125-49-92-(3-Cyclopropyl-6-ethyl-4-(trifluoromethyl)-1H-pyrazolo[3,4-b]pyridin-1-yl)acetic acidCAS 1018128-07-8Isopropyl 4-chloro-2-methylquinoline-6-carboxylateCAS 1018142-22-76-cyclopropyl-1-(2,2-difluoroethyl)-3-methyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acidCAS 1018144-00-72-(3-Cyclopropyl-6-isopropyl-4-(trifluoromethyl)-1H-pyrazolo[3,4-b]pyridin-1-yl)acetic acid

RFQ questions for CAS 259793-96-9

What are the key identifiers for Favipiravir (CAS 259793-96-9)?

Favipiravir is identified by CAS 259793-96-9, with molecular formula C5H4FN3O2, molecular weight 157.1, InChIKey ZCGNOVWYSGBHAU-UHFFFAOYSA-N.

Does CAS 259793-96-9 have reported biological target evidence?

ChEMBL contains qualifying experimental assay evidence associated with Alpha-1A adrenergic receptor, Muscarinic acetylcholine receptor M1, Prostaglandin G/H synthase 1, Protein deacetylase HDAC6, Thromboxane A2 receptor. These records do not establish therapeutic efficacy or clinical use.

Can I request a COA for CAS 259793-96-9?

Yes. Submit an RFQ and specify COA requirements. Lot-specific COA depends on supplier confirmation.

Can I request supplier SDS for Favipiravir?

Yes. Supplier SDS can be requested through the RFQ workflow before handling, storage, shipment, or procurement decisions.

Is CAS 259793-96-9 available for quotation?

Availability, pack size, lead time, and pricing are confirmed through RFQ.

Can MolGraph support bulk sourcing or custom synthesis review?

Submit the CAS number, quantity, purity requirement, and destination country for sourcing review.